Literature DB >> 26064197

Role of Rho kinase signal pathway in inflammatory bowel disease.

Yuan Huang1, Shiyu Xiao1, Quanhang Jiang1.   

Abstract

Inflammatory Bowel Disease (IBD) is nonspecific inflammation in the intestinal track, including Ulcerative Colitis (UC) and Crohn's disease (CD). The incidence of IBD has increased significantly, with its numerous rising up to five million globally, more than 1,700,000 in China. Pathological character of IBD is the inflammation of intestinal mucosa and intestinal fibrosis. Although the pathogenesis of the disease has not yet been fully clarified, some evidence suggests that excessive intestinal inflammation reaction, intestinal barrier impairment and abnormal immune response can initiate IBD. As research continues, some of them have provided new insights toward understanding of Rho kinase signal pathway function at the occurrence and development of IBD. This review aims to summarize the general principles of Rho kinase signal pathway in the pathological procedure of IBD.

Entities:  

Keywords:  IBD; Rho/Rho kinase; intestinal barrier; intestinal fibrosis

Year:  2015        PMID: 26064197      PMCID: PMC4443031     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  53 in total

1.  Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia.

Authors:  S V Walsh; A M Hopkins; J Chen; S Narumiya; C A Parkos; A Nusrat
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 2.  Intestinal barrier: an interface between health and disease.

Authors:  Ashkan Farhadi; Ali Banan; Jeremy Fields; Ali Keshavarzian
Journal:  J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 4.029

Review 3.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

Review 4.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

5.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

6.  Cellular contractility changes are sufficient to drive epithelial scattering.

Authors:  Jacob P Hoj; John A Davis; Kendra E Fullmer; David J Morrell; Nicholas E Saguibo; Jeffrey T Schuler; Kevin J Tuttle; Marc D H Hansen
Journal:  Exp Cell Res       Date:  2014-04-26       Impact factor: 3.905

7.  Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.

Authors:  D Beddy; J Mulsow; R W G Watson; J M Fitzpatrick; P R O'Connell
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

8.  Rho kinase signalling mediates radiation-induced inflammation and intestinal barrier dysfunction.

Authors:  A Mihaescu; S Santén; B Jeppsson; H Thorlacius
Journal:  Br J Surg       Date:  2010-09-29       Impact factor: 6.939

9.  Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.

Authors:  Kristin Schram; Riya Ganguly; Eun Kyung No; Xiangping Fang; Farah S L Thong; Gary Sweeney
Journal:  Endocrinology       Date:  2011-03-08       Impact factor: 4.736

Review 10.  TGF-beta-induced epithelial to mesenchymal transition.

Authors:  Jian Xu; Samy Lamouille; Rik Derynck
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

View more
  14 in total

Review 1.  Inflammatory bowel disease related innate immunity and adaptive immunity.

Authors:  Yuan Huang; Zhonge Chen
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Regulatory annotation of genomic intervals based on tissue-specific expression QTLs.

Authors:  Tianlei Xu; Peng Jin; Zhaohui S Qin
Journal:  Bioinformatics       Date:  2020-02-01       Impact factor: 6.937

3.  Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.

Authors:  Nibrass Taher Abdali; Awny H Yaseen; Eman Said; Tarek M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-18       Impact factor: 3.000

Review 4.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

5.  ROCK1 inhibitor stabilizes E-cadherin and improves barrier function in experimental necrotizing enterocolitis.

Authors:  Christie Buonpane; Carrie Yuan; Douglas Wood; Guillermo Ares; Samuel C Klonoski; Catherine J Hunter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

6.  Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis.

Authors:  Yuli Lin; Bingji Li; Xuguang Yang; Ting Liu; Tiancong Shi; Bo Deng; Yubin Zhang; Lijun Jia; Zhengfan Jiang; Rui He
Journal:  Mucosal Immunol       Date:  2019-09-18       Impact factor: 7.313

Review 7.  Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy.

Authors:  Margien L Seinen; Geerten P van Nieuw Amerongen; Nanne K H de Boer; Adriaan A van Bodegraven
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 8.  Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability.

Authors:  Lijun Du; John J Kim; Jinhua Shen; Ning Dai
Journal:  Gastroenterol Res Pract       Date:  2016-09-26       Impact factor: 2.260

Review 9.  Reactive oxygen species and antioxidant defense in human gastrointestinal diseases.

Authors:  Peter Patlevič; Janka Vašková; Pavol Švorc; Ladislav Vaško; Pavol Švorc
Journal:  Integr Med Res       Date:  2016-07-29

Review 10.  Pathogenic mechanisms of pancreatitis.

Authors:  Murli Manohar; Alok Kumar Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.